| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $2,061,094 ) |
| | 2023 | 2023 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R24OD010947 | Resource for Nonhuman Primate Immune Reagents | 000 | 19 | NIH | 3/15/2023 | $431,279 |
| | 2023 | 2023 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | U19AI142636 | Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels | 001 | 6 | NIH | 5/17/2023 | $1,629,815 |
| | 2023 | 2022 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | U19AI142636 | Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels | 000 | 5 | NIH | 4/10/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $5,571,062 ) |
| | 2022 | 2022 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R01MH125395 | Identification of SIV replication and reservoirs in the CNS | 000 | 3 | NIH | 7/20/2022 | $419,063 |
| | 2022 | 2022 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | U19AI142636 | Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels | 001 | 5 | NIH | 8/25/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | U19AI142636 | Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels | 000 | 5 | NIH | 5/19/2022 | $1,615,853 |
| | 2022 | 2022 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R01MH125395 | Identification of SIV replication and reservoirs in the CNS | 000 | 3 | NIH | 7/20/2022 | $419,065 |
| | 2022 | 2022 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R21AI165939 | Understanding the pathophysiology of GBS UTI in diabetes | 000 | 2 | NIH | 8/22/2022 | $171,742 |
| | 2022 | 2022 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | C06OD034041 | ?Renovation of Building 29 laboratories at the New Iberia Research Center" | 000 | 1 | NIH | 9/19/2022 | $2,000,000 |
| | 2022 | 2022 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R24OD010947 | Resource for Nonhuman Primate Immune Reagents | 000 | 18 | NIH | 6/23/2022 | $437,988 |
| | 2022 | 2022 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R01AI139288 | Whole body to single cell analysis of the HIV reservoir | 000 | 5 | NIH | 3/1/2022 | $708,265 |
| | 2022 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | P01AI048240 | Defense-in-depth against mucosal HIV clade C invasion | 000 | 16 | NIH | 6/30/2022 | $0 |
| | 2022 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | P01AI048240 | Defense-in-depth against mucosal HIV clade C invasion | 000 | 16 | NIH | 6/30/2022 | $0 |
| | 2022 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R21NS112910 | Determining the pathogenesis of DYT1 dystonia in reprogrammed human neurons | 001 | 1 | NIH | 2/19/2022 | -$200,913 |
| | 2022 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R21NS112910 | Determining the pathogenesis of DYT1 dystonia in reprogrammed human neurons | 002 | 1 | NIH | 8/17/2022 | -$1 |
| | 2022 | 2018 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R01AI111907 | Monitoring SIV Reservoirs with Whole Body immunoPET | 000 | 6 | NIH | 9/23/2022 | $0 |
| | 2022 | 2008 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E University Cir 3rd Fl | lafayette | LA | 70503-2014 | LAFAYETTE | USA | E4CHP18020 | NSL - Baccalaureate Nursing | 002 | 1 | HRSA | 10/18/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $6,795,986 ) |
| | 2021 | 2021 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R01AI139288 | Whole body to single cell analysis of the HIV reservoir | 000 | 4 | NIH | 1/27/2021 | $718,955 |
| | 2021 | 2021 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | U19AI142636 | Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels | 001 | 4 | NIH | 5/5/2021 | $1,719,534 |
| | 2021 | 2021 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R01MH125395 | Identification of SIV replication and reservoirs in the CNS | 000 | 2 | NIH | 7/16/2021 | $419,063 |
| | 2021 | 2021 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R01MH125395 | Identification of SIV replication and reservoirs in the CNS | 000 | 2 | NIH | 7/16/2021 | $419,065 |
| | 2021 | 2021 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R21AI165939 | Understanding the pathophysiology of GBS UTI in diabetes | 000 | 1 | NIH | 9/24/2021 | $208,856 |
| | 2021 | 2021 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R15GM144944 | Development of a new computational method for predicting drug - target interactions using a TSR-based representation of 3-D structures | 000 | 1 | NIH | 9/13/2021 | $420,456 |
| | 2021 | 2021 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | C06OD032071 | Novel Macaque Breeding Runs at the New Iberia Research Center | 000 | 1 | NIH | 9/20/2021 | $3,506,529 |
| | 2021 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | U19AI142636 | Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels | 000 | 3 | NIH | 11/18/2020 | $0 |
| | 2021 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | U19AI142636 | Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels | 002 | 3 | NIH | 5/18/2021 | $0 |
| | 2021 | 2018 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R01AI111907 | Monitoring SIV Reservoirs with Whole Body immunoPET | 000 | 6 | NIH | 4/29/2021 | -$616,472 |
| | 2021 | 2016 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R15GM120663 | Enantioselective C-H Amination of Alkenes and Carbonyl Compounds and Novel Application Thereof | 000 | 1 | NIH | 2/6/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $10,812,755 ) |
| | 2020 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | U19AI142636 | Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels | 002 | 3 | NIH | 5/4/2020 | $1,855,534 |
| | 2020 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | U19AI142636 | Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels | 004 | 3 | NIH | 7/8/2020 | $200,416 |
| | 2020 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | U19AI142636 | Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels | 005 | 3 | NIH | 7/8/2020 | -$200,416 |
| | 2020 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R21NS112910 | Determining the pathogenesis of DYT1 dystonia in reprogrammed human neurons | 000 | 1 | NIH | 3/18/2020 | $398,750 |
| | 2020 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R21NS112910 | Determining the pathogenesis of DYT1 dystonia in reprogrammed human neurons | 001 | 1 | NIH | 3/27/2020 | $0 |
| | 2020 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R01MH125395 | Identification of SIV replication and reservoirs in the CNS | 000 | 1 | NIH | 9/19/2020 | $444,374 |
| | 2020 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | P01AI048240 | Defense-in-depth against mucosal HIV clade C invasion | 002 | 16 | NIH | 6/30/2020 | $1,753,429 |
| | 2020 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | P01AI048240 | Defense-in-depth against mucosal HIV clade C invasion | 002 | 16 | NIH | 6/30/2020 | $1,765,650 |
| | 2020 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R01AI139288 | Whole body to single cell analysis of the HIV reservoir | 000 | 3 | NIH | 2/14/2020 | $729,273 |
| | 2020 | 2020 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R01MH125395 | Identification of SIV replication and reservoirs in the CNS | 000 | 1 | NIH | 9/19/2020 | $431,064 |
| | 2020 | 2019 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | U19AI142636 | Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels | 008 | 2 | NIH | 7/27/2020 | -$1,831 |
| | 2020 | 2019 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | U19AI142636 | Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels | 006 | 2 | NIH | 7/8/2020 | $200,416 |
| | 2020 | 2019 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | U19AI142636 | Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels | 001 | 2 | NIH | 2/1/2020 | $727,169 |
| | 2020 | 2019 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | P01AI048240 | Defense-in-depth against mucosal HIV clade C invasion | 001 | 15 | NIH | 4/14/2020 | $2,508,927 |
| | 2020 | 2018 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R24OD010947 | Resource for Nonhuman Primate Immune Reagents | 000 | 17 | NIH | 7/14/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $5,139,468 ) (Continued on the next page) |
| | 2019 | 2019 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | P01AI048240 | Defense-in-depth against mucosal HIV clade C invasion | 002 | 15 | NIH | 9/4/2019 | $2,646,758 |
| | 2019 | 2019 | UNIVERSITY OF LOUISIANA AT LAFAYETTE | 104 E UNIVERSITY CIR 3RD FL | LAFAYETTE | LA | 70503-2014 | LAFAYETTE | USA | R01AI139288 | Whole body to single cell analysis of the HIV reservoir | 000 | 2 | NIH | 2/22/2019 | $739,281 |
|
